Press Release: New nirsevimab data analyses reinforce efficacy against RSV

06:00am, Wednesday, 11'th May 2022 GlobeNewswire Inc.
New nirsevimab data analyses reinforce efficacy against RSV
Ken Fisher’s 13F portfolio value decreased from ~$179B to ~$165B in Q1 2022. Find more details here...

Press Release: Foundation S: Sanofi’s new philanthropic spearhead

10:00am, Wednesday, 04'th May 2022 GlobeNewswire Inc.

Press Release: Annual General Meeting of May 3, 2022

05:00pm, Tuesday, 03'rd May 2022 GlobeNewswire Inc.
Santander Looks Cheap At 6.3x P/E And 0.65x Tangible Book Value
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1
Poursuite de la forte hausse du BNPA des activités(1) portée par la croissance des ventes et des marges au T1 Paris, le 28 avril 2022

Banco Santander Central Hispano (SAN) Q1 2022 Earnings Call Transcript

05:30am, Wednesday, 27'th Apr 2022 The Motley Fool
SAN earnings call for the period ending March 31, 2022.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
Banco Santander SA (NYSE:SAN ) Q1 2022 Earnings Conference Call April 26, 2022 4:00 AM ET Company Participants Jose Antonio Alvarez - CEO & Vice Chairman Jose Garcia-Cantera - Senior EVP & Group CFO C
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE